ClinicalTrials.gg
Not yet recruitingNCT07820020Updated Sep 24, 2026

Effectiveness of a Psychological Intervention to Reduce Social Isolation and Promote Social Connectedness in Young Adults

An interventional study of Digital-Assisted Group Social Skills Training in Social Isolation, Loneliness and Social Skills, sponsored by Korea University. Not yet recruiting. Open to participants aged 19 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Korea University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
19 Years to 34 Years
Sex
All
01

Study summary

The purpose of this randomized controlled trial is to evaluate the effectiveness of a psychological intervention aimed at reducing social isolation and promoting social connectedness among young adults. Specifically, the study investigates the impact of an 8-week, digitally assisted face-to-face group social skills training program on individuals aged 19 to 34 who experience difficulties in interpersonal relationships and social isolation. Participants will be randomly assigned to either the active intervention group or a waitlist control group. The study aims to determine whether this structured psychosocial intervention improves interpersonal competence and social performance, reduces social isolation, and improves other psychosocial variables. Outcomes will be evaluated at three time points-pre-intervention, post-intervention, and a 1-month follow-up-utilizing a combination of self-report questionnaires and performance-based role-play assessments.

02

Conditions studied

  • Social Isolation
  • Loneliness
  • Social Skills
03

In context

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Lead sponsor

Korea University is the lead sponsor of 64 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 34 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 19 to 34 years
  • South Korean nationality
  • Interpersonal Competence Questionnaire, 15-item short form (ICQ-15): mean score of 2.87 or lower
  • Meets either (a) or (b) below:
  • (a) Lubben Social Network Scale-6 (LSNS-6) total score of less than 12, AND short-form UCLA Loneliness Scale-8 total score of 17 or higher
  • (b) Korea University Social Isolation Scale (KUSIS) total score of 9 or higher
  • Confirmation on a non-face-to-face screening interview that the participant's primary difficulty involves interpersonal problems stemming from a lack of social knowledge and skills

Exclusion criteria

Exclusion Criteria:

  • Psychiatric or neurological hospitalization within the past 6 months
  • Current or past diagnosis of a severe neurological disorder
  • Cognitive impairment severe enough to hinder the basic communication required for program participation
  • Suicide attempt within the past 6 months
  • Severe suicide risk identified during the assessment
  • History of psychotic symptoms or manic episodes
  • Severe psychiatric condition or major medical abnormality that would complicate participation
  • Unable or unwilling to follow the research team's instructions during the application process
  • Currently participating in individual or group psychotherapy that provides training in other social skills
  • Participation within the past 5 years in a study on social isolation conducted by an investigator of the present research team, which raises concern for a confounding effect on the study results
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • No intervention
    Waitlist Control
  • Experimental
    Digital-Assisted Group Social Skills Training

    Behavioral: Digital-Assisted Group Social Skills Training

Interventions

  • BehavioralDigital-Assisted Group Social Skills Training

    Participants assigned to the active intervention arm receive an 8-week, face-to-face group social skills training program, which involves weekly 120-minute sessions supplemented by a web-based digital platform designed to promote between-session practice and skill generalization.

06

What researchers measure

Primary outcomes

  1. Korean Version of the Interpersonal Competence Questionnaire (K-ICQ)

    The Korean Version of the Interpersonal Competence Questionnaire (K-ICQ) is a 31-item self-report measure of interpersonal competence. Each item is rated on a 5-point Likert scale from 1 (poor) to 5 (extremely good). The total score sums all items and ranges from 31 to 155. Higher scores indicate greater interpersonal competence, which is a better outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  2. Social Skills Knowledge Test

    The Social Skills Knowledge Test is an investigator-developed knowledge test created to objectively measure acquisition of the social skills content taught in the intervention. It consists of 21 items (multiple-choice and true/false) covering seven domains that correspond to the session curriculum: relationship formation skills, conversation skills I, conversation skills II, assertion skills, conflict management skills, dating skills, and workplace skills, with 3 items per domain. Each item has an unambiguously correct answer and is scored 1 (correct) or 0 (incorrect). The total score is the sum of correct responses and ranges from 0 to 21. Higher scores indicate greater knowledge of social skills, which is a better outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  3. Korea University Social Isolation Scale (KUSIS)

    The Korea University Social Isolation Scale (KUSIS) is a 9-item self-report measure of social isolation risk. Respondents rate their state over the past month, excluding people they currently live with. Each item is rated on a 4-point scale from 0 (never) to 3 (very much). The total score sums all items and ranges from 0 to 27, with a cut-off of 9 or higher indicating risk of social isolation. Higher scores indicate greater social isolation, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

Secondary outcomes

  1. Lubben Social Network Scale-6 (LSNS-6)

    The Lubben Social Network Scale-6 (LSNS-6) is a 6-item self-report measure of social network size and engagement; three items concern family and relatives, and three concern friends and other acquaintances. Each item is rated on a 6-point scale from 0 (none) to 5 (nine or more people). The total score sums all items and ranges from 0 to 30. Higher scores indicate a larger and more engaged social network, which is a better outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  2. Short-form UCLA Loneliness Scale-8

    The short-form UCLA Loneliness Scale-8 (ULS-8) is an 8-item self-report measure of loneliness abbreviated from the 20-item UCLA Loneliness Scale. Each item is rated on a 4-point scale from 1 (never) to 4 (always); two positively worded items are reverse-scored. The total score is the sum of all items and ranges from 8 to 32. Higher scores indicate greater loneliness, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  3. Patient Health Questionnaire-9 (PHQ-9)

    The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms over the preceding two weeks, based on the DSM-IV diagnostic criteria for major depressive disorder. Each item is rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of all items and ranges from 0 to 27. Higher scores indicate more severe depressive symptoms, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  4. Generalized Anxiety Disorder-7 (GAD-7)

    The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item self-report measure of the core symptoms of generalized anxiety disorder over the preceding two weeks. Each item is rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of all items and ranges from 0 to 21. Higher scores indicate more severe anxiety symptoms, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  5. Korean version of the Social Interaction Anxiety Scale-Social Phobia Scale Short Form (K-SIAS-SPS-SF)

    The Korean version of the Social Interaction Anxiety Scale-Social Phobia Scale Short Form (K-SIAS-SPS-SF) is a single 14-item self-report measure of social anxiety. Its items were derived by exploratory factor analysis of the pooled 40-item set of the Social Interaction Anxiety Scale and the Social Phobia Scale, and the resulting instrument is administered and scored as one scale comprising three correlated factors: social interaction anxiety (5 items), fear of overt evaluation (6 items), and fear of attracting attention (3 items). Each item is rated on a 5-point scale from 0 (not at all characteristic of me) to 4 (extremely characteristic of me). A single total score is obtained by summing all 14 items and ranges from 0 to 56, with a total score of 22 or higher indicating probable social anxiety disorder. Higher scores indicate greater social anxiety, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  6. Mental Health Continuum-Short Form (MHC-SF)

    The Mental Health Continuum-Short Form (MHC-SF) is a 14-item self-report measure of positive mental health over the past month, comprising three subscales: emotional well-being (3 items), social well-being (5 items), and psychological well-being (6 items). Each item is rated on a 6-point frequency scale from 0 (never) to 5 (every day). The total score sums all items and ranges from 0 to 70. Higher scores indicate greater well-being, which is a better outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  7. Multidimensional Scale of Perceived Social Support (MSPSS)

    The Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item self-report measure of perceived social support from three sources: significant other, family, and friends, with 4 items per source. Each item is rated on a 7-point Likert scale from 1 (very strongly disagree) to 7 (very strongly agree). The total score sums all items and ranges from 12 to 84. Higher scores indicate greater perceived social support, which is a better outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

  8. Broad Autism Phenotype Questionnaire Short Form (BAPQ-SF)

    The Broad Autism Phenotype Questionnaire Short Form (BAPQ-SF) is a 14-item self-report measure that assesses core features of the autism spectrum as a continuous dimension in the general population. Each item is rated on a 6-point frequency scale from 1 (very rarely) to 6 (very often), and positively worded items are reverse-scored so that higher values reflect more pronounced traits. The total score sums all items and ranges from 14 to 84. Higher scores indicate more pronounced broad autism phenotype traits, which is a worse outcome.

    Time frame: Baseline, immediately post-intervention (at 8 weeks), and 1-month follow-up (at 12 weeks)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07820020
Lead sponsor
Korea University
Responsible party
KEE-HONG CHOI (Professor, Korea University) — Principal investigator
First posted
Sep 15, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
Oct 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Jaehee Jung
Contact
emqhfkwogml13@gmail.com
821073177521

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion